Search
Inmode Ltd
INMDAdd to Watchlist
14.800USD
+0.120+0.82%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
937.71MMarket Cap
10.81P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+0.82%
5 Days
+0.07%
1 Month
+8.90%
6 Months
+0.75%
Year to Date
+0.75%
1 Year
-0.20%
Key Figures
14.740Open
14.915High
688.25KVolume
10.81P/E TTM
10.63P/E Dynamic
--Dividend TTM
1.09%Turnover Ratio
14.680Prev. Close
14.715Low
7.28MTurnover
5.17P/E Static
1.37P/B
0.00%Div Yield TTM
11.98%ROA
16.74052wk High
1.46Volume Ratio
181.28MNet Profit
63.36MShares
1.3694EPS TTM
1.95Beta
13.62%ROE
12.72052wk Low
1.36%Amplitude
75.05%Gross Margin
937.71MMarket Cap
5.33Reward/Risk
1.66%Risk Rate
TradingKey Stock Score of Inmode Ltd
Currency: USD Updated: 2026-07-01Key Insights
Inmode Ltd's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 58 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 14.33.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Inmode Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Inmode Ltd Highlights
StrengthsRisks
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Overvalued
The company’s latest PE is 10.72, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 33.96M shares, decreasing 35.22% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.
Analyst Rating
Based on
6
analysts
Hold
Current Rating
14.333
Target Price
-2.76%
Upside Space
Inmode Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Inmode Ltd Info
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Ticker SymbolINMD
CompanyInmode Ltd
CEOMizrahy (Moshe)
Websitehttps://inmodemd.com/
Related Instruments
-0.37%
+1.91%
+3.48%
+5.87%
+2.10%
-0.10%
+4.19%
+5.03%
+4.30%
+0.25%
+3.65%
+4.74%
+2.79%
+2.59%
-3.06%
+3.76%
+3.40%
+1.10%
-2.09%
+3.50%Popular Instruments
FAQs
What is the current price of Inmode Ltd (INMD)?
The current price of Inmode Ltd (INMD) is 14.68.
What is the symbol of Inmode Ltd?
The ticker symbol of Inmode Ltd is INMD.
What is the 52-week high of Inmode Ltd?
The 52-week high of Inmode Ltd is 16.74.
What is the 52-week low of Inmode Ltd?
The 52-week low of Inmode Ltd is 12.72.
What is the market capitalization of Inmode Ltd?
The market capitalization of Inmode Ltd is 843.82M.
Is Inmode Ltd (INMD) currently rated as Buy, Hold, or Sell?
According to analysts, Inmode Ltd (INMD) has an overall rating of signal_hold, with a price target of 14.33.
What is the Earnings Per Share (EPS TTM) of Inmode Ltd (INMD)?
The Earnings Per Share (EPS TTM) of Inmode Ltd (INMD) is 1.45.